Terms: = Colorectal cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
65 results:
1. Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer.
Chen SH; Tse KP; Lu YJ; Chen SJ; Tian YF; Tan KT; Li CF
Cancer Med; 2024 Jun; 13(12):e7384. PubMed ID: 38895905
[TBL] [Abstract] [Full Text] [Related]
2. Role of diffusion-weighted imaging in response prediction and evaluation after high dose rate brachytherapy in patients with colorectal liver metastases.
Karim S; Seidensticker R; Seidensticker M; Ricke J; Schinner R; Treitl K; Rübenthaler J; Ingenerf M; Schmid-Tannwald C
Radiol Oncol; 2024 Mar; 58(1):33-42. PubMed ID: 38378033
[TBL] [Abstract] [Full Text] [Related]
3. Safety of high-dose rate (hdr) brachytherapy for patients with prostate cancer and history of prior chemoradiation for rectal cancer: A case series.
Thomas H; Chen JJ; Abdul-Baki H; Sabbagh A; Shaheen H; Chau OW; Malik N; Ayoub A; Hassanzadeh C; Hsu IC; Mohamad O
Brachytherapy; 2024; 23(2):173-178. PubMed ID: 38160102
[TBL] [Abstract] [Full Text] [Related]
4. Organ and Function Preservation in Gastrointestinal Malignancies.
Sur R; Than NW; Taggar A; Sripadam R; Sun Myint A
Clin Oncol (R Coll Radiol); 2023 Aug; 35(8):524-532. PubMed ID: 37357120
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
6. Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.
Fokas E; Glynne-Jones R; Fleischmann M; Piso P; Tselis N; Ghadimi M; Hofheinz RD; Rödel C
Cancer Treat Rev; 2023 Jan; 112():102490. PubMed ID: 36463667
[TBL] [Abstract] [Full Text] [Related]
7. Correlation of chemokines and growth factors with radiation-induced liver injury after interstitial high dose rate (hdr) brachytherapy of liver metastases.
Damm R; Pech M; Cavalli P; Haag F; Gylstorff S; Omari J; Thormann M; Seidensticker R; Ricke J; Seidensticker M; Relja B
J Cancer Res Clin Oncol; 2022 Oct; 148(10):2815-2826. PubMed ID: 35596772
[TBL] [Abstract] [Full Text] [Related]
8. Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach.
Fleischmann M; Diefenhardt M; Trommel M; Scherf C; Ramm U; Chatzikonstantinou G; Fokas E; Rödel C; Tselis N
Strahlenther Onkol; 2022 Jul; 198(7):654-662. PubMed ID: 35445815
[TBL] [Abstract] [Full Text] [Related]
9. High dose rate brachytherapy in the management of anal cancer: A review.
Ali ZS; Solomon E; Mann P; Wong S; Chan KKW; Taggar AS
Radiother Oncol; 2022 Jun; 171():43-52. PubMed ID: 35381275
[TBL] [Abstract] [Full Text] [Related]
10. Synergistic antitumor activity of 5-fluorouracil and atosiban against microsatellite stable colorectal cancer through restoring gata3.
Wang M; Guo X; Yang M; Zhang Y; Meng F; Chen Y; Chen M; Qiu T; Li J; Li Z; Zhang Q; Xu F; Zhang H; Wang W
Biochem Pharmacol; 2022 May; 199():115025. PubMed ID: 35367196
[TBL] [Abstract] [Full Text] [Related]
11. [Clinicopathological analysis of lung metastatic tumor].
Lou N; Niu YR; Yang F; Lu ZH
Zhonghua Bing Li Xue Za Zhi; 2021 Sep; 50(9):1039-1044. PubMed ID: 34496496
[No Abstract] [Full Text] [Related]
12. Radiotherapeutic treatment options for oligotopic malignant liver lesions.
Wust P; Beck M; Dabrowski R; Neumann O; Zschaeck S; Kaul D; Modest DP; Stromberger C; Gebauer B; Ghadjar P
Radiat Oncol; 2021 Mar; 16(1):51. PubMed ID: 33726751
[TBL] [Abstract] [Full Text] [Related]
13. Comprehensive analysis in mucin-producing urothelial-type adenocarcinoma of the prostate: case study with literature review.
Moe K; Maa HC; Pei D; Liang YJ; Chen YL
Pol J Pathol; 2020; 71(3):244-253. PubMed ID: 33112115
[TBL] [Abstract] [Full Text] [Related]
14. Sphincter-saving surgery for ultra-low rectal carcinoma initially indicated for abdominoperineal resection: Is it safe on a long-term follow-up?
Rouanet P; Rivoire M; Gourgou S; Lelong B; Rullier E; Jafari M; Mineur L; Pocard M; Faucheron JL; Dravet F; Pezet D; Fabre JM; Bresler L; Balosso J; Taoum C; Lemanski C
J Surg Oncol; 2021 Jan; 123(1):299-310. PubMed ID: 33098678
[TBL] [Abstract] [Full Text] [Related]
15. Advanced design, simulation, and dosimetry of a novel rectal applicator for contact brachytherapy with a conventional hdr
Bellezzo M; Fonseca GP; Voncken R; Verrijssen AS; Van Beveren C; Roelofs E; Yoriyaz H; Reniers B; Van Limbergen EJ; Berbée M; Verhaegen F
Brachytherapy; 2020; 19(4):544-553. PubMed ID: 32386884
[TBL] [Abstract] [Full Text] [Related]
16. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.
Duque AS; Corradini S; Kamp F; Seidensticker M; Streitparth F; Kurz C; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Fonseca GP; Landry G
Radiat Oncol; 2020 Mar; 15(1):60. PubMed ID: 32151255
[TBL] [Abstract] [Full Text] [Related]
17. High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
Varela Cagetti L; Zemmour C; Salem N; Minsat M; Ferrè M; Mailleux H; Giovaninni M; Lelong B; De Chaisemartin C; Ries P; Poizat F; Tallet A; Moureau-Zabotto L
Brachytherapy; 2019; 18(6):814-822. PubMed ID: 31515067
[TBL] [Abstract] [Full Text] [Related]
18. Dosimetric Considerations for Ytterbium-169, Selenium-75, and Iridium-192 Radioisotopes in High-Dose-Rate Endorectal Brachytherapy.
Shoemaker T; Vuong T; Glickman H; Kaifi S; Famulari G; Enger SA
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):875-883. PubMed ID: 31330175
[TBL] [Abstract] [Full Text] [Related]
19. A systematic review comparing radiation toxicity after various endorectal techniques.
Verrijssen AS; Opbroek T; Bellezzo M; Fonseca GP; Verhaegen F; Gerard JP; Sun Myint A; Van Limbergen EJ; Berbee M
Brachytherapy; 2019; 18(1):71-86.e5. PubMed ID: 30396854
[TBL] [Abstract] [Full Text] [Related]
20. Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Jönsson P; Mattsson JSM; Botling J; Micke P; Brunnström H
Hum Pathol; 2019 Feb; 84():221-230. PubMed ID: 30389437
[TBL] [Abstract] [Full Text] [Related]
[Next]
